{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:33:30Z","timestamp":1787776410205,"version":"build-2784847793"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2014,1,15]],"date-time":"2014-01-15T00:00:00Z","timestamp":1389744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0085889","type":"journal-article","created":{"date-parts":[[2014,1,15]],"date-time":"2014-01-15T21:43:44Z","timestamp":1389822224000},"page":"e85889","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":47,"title":["High Rate of Per Oral Mecillinam Treatment Failure in Community-Acquired Urinary Tract Infections Caused by ESBL-Producing Escherichia coli"],"prefix":"10.1371","volume":"9","author":[{"given":"Arne","family":"S\u00f8raas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnfinn","family":"Sundsfjord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silje Bakken","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut","family":"Liest\u00f8l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l A.","family":"Jenum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,1,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1469-0691.2007.01852.x","article-title":"Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline","volume":"14","author":"J Garau","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/jac\/46.suppl_1.9","article-title":"Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases","volume":"46","author":"W Sougakoff","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"K Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Dewar S, Reed LC, Koerner RJ (2013) Emerging clinical role of pivmecillinam in the treatment of urinary tract infection in the context of multidrug-resistant bacteria. J Antimicrob Chemother.","DOI":"10.1093\/jac\/dkt368"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1179\/joc.2001.13.3.299","article-title":"Effect of perorally administered pivmecillinam on the normal oropharyngeal, intestinal and skin microflora","volume":"13","author":"A Sullivan","year":"2001","journal-title":"J Chemother"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1128\/AAC.49.1.170-175.2005","article-title":"Ecological effects of perorally administered pivmecillinam on the normal vaginal microflora","volume":"49","author":"A Sullivan","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijantimicag.2011.09.013","article-title":"Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO.SENS study revisited","volume":"39","author":"G Kahlmeter","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"ref8","unstructured":"NORM\/NORM-VET 2010 (2011) Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway. Troms\u00f8\/Oslo 2011. ISSN:1502\u20132307 (print)\/1890\u20139965 (electronic)."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s10096-011-1183-4","article-title":"In vitro activity of beta-lactam antibiotics against CTX-M-producing Escherichia coli","volume":"30","author":"M Tarnberg","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1089\/mdr.2011.0161","article-title":"Efficacy of pivmecillinam for treatment of lower urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae","volume":"18","author":"E Titelman","year":"2012","journal-title":"Microb Drug Resist"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1128\/AAC.01760-09","article-title":"Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli","volume":"54","author":"S Auer","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/jac\/dkp404","article-title":"Activity of mecillinam against Escherichia coli resistant to third-generation cephalosporins","volume":"65","author":"M Wootton","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1093\/jac\/dks215","article-title":"Mecillinam\/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli","volume":"67","author":"N Lampri","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/jac\/dki451","article-title":"Activity of mecillinam against ESBL producers in vitro","volume":"57","author":"K Thomas","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1080\/00365540701367801","article-title":"Successful treatment of ctx-m ESBL producing Escherichia coli relapsing pyelonephritis with long term pivmecillinam","volume":"39","author":"LE Nicolle","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e69581","DOI":"10.1371\/journal.pone.0069581","article-title":"Risk Factors for Community-Acquired Urinary Tract Infections Caused by ESBL-Producing Enterobacteriaceae -A Case-Control Study in a Low Prevalence Country","volume":"8","author":"A Soraas","year":"2013","journal-title":"PLoS One"},{"key":"ref17","unstructured":"Berg C, Furu K, Mahic M, Litleskare I, R\u00f8nning M <etal>et al<\/etal>.. (2011) The Norwegian Prescription Database 2006\u20132010: The Norwegian Institute of Public Health. ISBN: 978-82-8082-458-5."},{"key":"ref18","unstructured":"European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.eucast.org\/Accessed\" xlink:type=\"simple\">http:\/\/www.eucast.org\/Accessed<\/ext-link> 1 October 2013."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1099\/jmm.0.46909-0","article-title":"Real-time TaqMan PCR for rapid detection and typing of genes encoding CTX-M extended-spectrum beta-lactamases","volume":"56","author":"CI Birkett","year":"2007","journal-title":"J Med Microbiol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1128\/JCM.01319-06","article-title":"Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway","volume":"45","author":"S Tofteland","year":"2007","journal-title":"J Clin Microbiol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/jac\/48.6.895","article-title":"Antibiotic failure in the treatment of urinary tract infections in young women","volume":"48","author":"RA Lawrenson","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1365-2125.2004.02106.x","article-title":"Increased treatment failure after 3-days&apos; courses of nitrofurantoin and trimethoprim for urinary tract infections in women: a population-based retrospective cohort study using the PHARMO database","volume":"58","author":"WG Goettsch","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/pri.20.2.97.101","article-title":"Treatment failures after antibiotic therapy of uncomplicated urinary tract infections. A prescription database study","volume":"20","author":"L Bjerrum","year":"2002","journal-title":"Scand J Prim Health Care"},{"key":"ref24","first-page":"360","article-title":"Understanding interobserver agreement: the kappa statistic","volume":"37","author":"AJ Viera","year":"2005","journal-title":"Fam Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3904\/kjim.2012.27.2.128","article-title":"Current epidemiology and growing resistance of gram-negative pathogens","volume":"27","author":"DM Livermore","year":"2012","journal-title":"Korean J Intern Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/mdr.2010.0132","article-title":"The CTX-M conundrum: dissemination of plasmids and Escherichia coli clones","volume":"17","author":"U Naseer","year":"2011","journal-title":"Microb Drug Resist"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0891-5520(03)00065-5","article-title":"Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid","volume":"17","author":"WA Craig","year":"2003","journal-title":"Infect Dis Clin North Am"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1469-0691.2004.00737.x","article-title":"Urinary concentrations and urine ex-vivo effect of mecillinam and sulphamethizole","volume":"10","author":"MB Kerrn","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"ref29","unstructured":"Jensen KS, Henriksen AS, Frimodt-Moeller N (2008) Pivmecillinam: estimation of adequate dosage for susceptible and ESBL-producing <italic>E. coli<\/italic> by Monte Carlo PK\/PD simulation. Abstracts of the 18nd European Congress of Clinical Microbiology and Infectious Diseases, Barcelona, Spain, 2008 Abstract P1255 European Society of Clinical Microbiology and Infectious Diseases, Basel, Switzerland."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/AAC.44.1.156-163.2000","article-title":"Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies","volume":"44","author":"H Hvidberg","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0924-8579(02)00105-X","article-title":"Correlation between pharmacokinetic\/pharmacodynamic parameters and efficacy for antibiotics in the treatment of urinary tract infection","volume":"19","author":"N Frimodt-Moller","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/02813430802535312","article-title":"Pivmecillinam versus sulfamethizole for short-term treatment of uncomplicated acute cystitis in general practice: a randomized controlled trial","volume":"27","author":"L Bjerrum","year":"2009","journal-title":"Scand J Prim Health Care"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0924-8579(99)00118-1","article-title":"Comparison of pivmecillinam and cephalexin in acute uncomplicated urinary tract infection","volume":"13","author":"AP Menday","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/02813430601183074","article-title":"Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project","volume":"25","author":"SA Ferry","year":"2007","journal-title":"Scand J Prim Health Care"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/00365540110080728","article-title":"Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women","volume":"34","author":"LE Nicolle","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1086\/313596","article-title":"Recurrent urinary tract infections in postmenopausal women","volume":"30","author":"R Raz","year":"2000","journal-title":"Clin Infect Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0085889","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T02:08:02Z","timestamp":1588990082000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0085889"}},"subtitle":[],"editor":[{"given":"Dongsheng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,15]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0085889","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,15]]}}}